A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors

por Wagner, A. J., Kindler, H., Gelderblom, H., Schöffski, P., Bauer, S., Hohenberger, P., Kopp, H.-G., Lopez-Martin, J. A., Peeters, M., Reichardt, P., Qin, A., Nippgen, J., Ilaria, R. L., Rutkowski, P.
Publicado 2017